About AEO Dose

Built Around One Practical Question

As buyers increasingly use AI assistants to research suppliers and manufacturers, can pharma businesses clearly communicate who they are, what they make and why they are credible? AEO Dose was created to answer that question, methodically.

Pharma domain knowledge meets AI visibility testing
Our Story

Why AEO Dose Was Built Around One Practical Question

AEO Dose was created around a practical question: as buyers increasingly use AI assistants to research suppliers and manufacturers, can pharma businesses clearly communicate who they are, what they make and why they are credible?

Our work brings together pharmaceutical domain understanding, digital information structure and systematic AI visibility testing. We help businesses move from guesswork to a repeatable process: establish a baseline, identify specific gaps, improve the information available to AI systems and measure again.

The result is not a vague score or a promised ranking. It is a clear, honest picture of where your brand stands today and what to do next.

Pharmaceutical researcher reviewing structured information at a workstation

5 AI platforms tested in every full audit

Our Mission

Closing the Information Gap Between Pharma Expertise and AI Systems

Pharma businesses often have specialized products, technical capabilities and years of industry experience, but that information is not always easy for AI systems to identify and connect. AEO Dose exists to help close that information gap, so buyers can more easily discover relevant businesses and evaluate their stated capabilities.

Our role is not to promise an AI recommendation. It is to help companies make their information clearer, more consistent, more useful and easier to verify, whether they are an API manufacturer, a CDMO or a raw-material supplier trying to be found and understood correctly.

Make information findable
Help AI systems locate and connect the right information about your pharma capabilities.
Make claims verifiable
Ensure capabilities and credentials are supported by consistent, structured, credible sources.
Measure before and after
Establish a real baseline and re-test so improvements are observable, not assumed.
No guarantees, only honesty
We never promise an AI recommendation. We provide observable gaps and practical steps you can act on.
Pharma buyer-question sets:Discovery, evaluation, capability, commercial and support
5 AI platforms: ChatGPT, Gemini, Perplexity, Claude and Grok
Regulated-industry awareness:Quality, compliance and documentation context
Website AEO readiness: Schema, content structure and entity clarity
OUR Approach

Pharma Domain Knowledge, Built into Every Audit

AEO Dose is built around how pharmaceutical buyers actually look for suppliers, manufacturers and technical partners. Our audits reflect the terminology, documentation expectations and quality-focused thinking of regulated industries, so the questions we test and the findings we report match real procurement conversations.

Pharma businesses depend on information that is structured, consistent and verifiable. That same discipline shapes how AEO Dose approaches AI visibility: clear entity descriptions, relevant structured data, credible third-party references and question-led content.

Every recommendation traces back to a gap observed in actual AI platform testing, not to a general best practice or a promised ranking.

Our MIssion
"The pharmaceutical industry deserves accurate, credible and meaningful representation in the AI-driven world. At AEO Dose, our mission is to help pharma businesses become more visible, trusted and discoverable wherever people seek answers."
Our Focus

Visibility Measurement, Readiness and Benchmarking

Everything we do is built around five practical areas of focus. Together they turn an unclear picture of AI visibility into a prioritized, workable plan.

01
AI Visibility Measurement
Testing against real customer and procurement questions, not generic keyword guesses. We measure what buyers actually ask AI assistants, across five buyer journey stages.
02
Website AEO Readiness
Evaluating content clarity, information structure, metadata and relevant structured data so AI systems can accurately read and represent your capabilities.
03
Competitive Benchmarking
Understanding where other brands are more visible in AI answers and why, so you can identify realistic opportunities rather than chase arbitrary targets.
04
Question-Led Content Planning
Building content strategies from identified visibility gaps across the buyer journey, so each piece of content addresses a real discovery or evaluation need.
05
Prioritization and Repeat Measurement
Practical prioritization ranked by impact and effort, with repeat measurement to confirm what changed, rather than unsupported promises about AI placement.
How We Think

Evidence Before Assumptions, Questions Before Keywords

Our approach is methodical because pharma decisions deserve care, not hype. We start from what is observable and testable, and we build recommendations from there.

We do not claim to control what an AI system says about your brand. We help you understand what it currently says, why, and what can realistically be improved.

  • Evidence before assumptions
    Every finding is drawn from actual AI platform testing, not inferred from traffic data or search rankings.
  • Questions before keywords
    We build test sets from real buyer questions, not keyword lists, because that is how people actually use AI assistants.
  • Clear information before clever claims
    AI systems reward clarity and consistency. We help you communicate plainly and correctly before optimizing anything else.
  • Useful recommendations before vanity scores
    Every finding in an AEO Dose report connects to a concrete action you can take, not an index number to screenshot.
  • Repeat measurement before declaring success
    We retest after improvements so you have a real before-and-after picture, not a guess about whether things got better.
See The Work

Explore an Illustrative AEO Audit Report

The sample report demonstrates how an assessment can organize visibility observations, buyer-question gaps, website-readiness findings and prioritized recommendations.

It demonstrates the reporting structure; it does not disclose client findings or claim actual performance.

Explore the Sample Audit Report
Questions

About AEO Dose

Common questions about who we are and how we work.

What is AEO Dose and who is it for?
AEO Dose helps pharma manufacturers, CDMOs, excipient suppliers and nutraceutical brands measure their visibility in AI answers, identify gaps and improve discovery across ChatGPT, Gemini, Perplexity, Claude and Grok. It is designed for businesses in regulated and specialized sectors where accurate, credible AI representation matters for buyer discovery and evaluation.
What makes AEO Dose different from a standard SEO or digital agency?
AEO Dose is built on pharmaceutical domain knowledge, not general digital marketing. Our question sets, gap analysis and recommendations reflect how pharma procurement actually works, including technical, quality and regulatory considerations, rather than how e-commerce or SaaS buyers behave.
Do you guarantee that AI platforms will recommend my brand?
No. AEO Dose does not promise guaranteed rankings or AI recommendations. AI platforms make their own decisions about what to surface. What we provide are observable gaps, honest findings and practical steps you can act on. Our commitment is to accuracy and usefulness, not to outcomes we cannot control.
What is the background behind the AEO Dose methodology?
The methodology is built on a principle familiar to every regulated industry: information should be structured, consistent and verifiable. That shapes how AEO Dose approaches AI visibility. Structured data, clear entity descriptions, credible third-party references and question-led content are the building blocks, and every recommendation traces back to an observed gap rather than a general best practice.
How do I start working with AEO Dose?
You can request a free AI Visibility Check from the homepage, which gives you a baseline across 2 platforms and 10 relevant buyer questions with no upfront commitment. If you would prefer to discuss a full audit first, you can use the contact page and we will respond within 1 to 2 business days.
Work With AEO Dose

Build Credible AI Visibility for Your Pharma Brand

If you want a clear, honest picture of how your pharma or healthcare brand shows up in AI answers, start with the free baseline or talk to us about a deeper audit.

Either way, you get specific findings grounded in real buyer questions, not vague promises or vanity scores.

No guaranteed-ranking promises Specific findings, not vague scores Pharma industry expertise